NIH-funded research R03 grant

Selective vulnerability of dopamine neurons in fruit flies

Official title: Selective Vulnerability of Dopaminergic Neurons in Drosophila

Funded at Lehigh University · NIH-11381059 · Data updated 2026-11-12

Researchers are studying why certain dopamine-producing brain cells in fruit flies are more likely to fail in neurodegenerative conditions, with the goal of informing protective strategies for people.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionLehigh University
NIH-funded
Lab location1 site (Bethlehem, United States)
Project startAugust 1, 2025
Project endJuly 31, 2027
Funding year2026
Award (this year)$77,615
NIH project number5R03NS144936-02
Project IDNIH-11381059 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with neurodegenerative conditions or a family history seeking to understand neuronal vulnerability; however, this grant is an animal-model study and does not involve direct patient participation.

Less likely to help

People seeking direct diagnostic or treatment options for Parkinson’s disease through this study would not participate.

What this research studies

This project looks at why some neurons in the brain are more vulnerable than others in neurodegenerative diseases like Parkinson’s. Using Drosophila, scientists will map which dopamine neurons are susceptible, test what makes them vulnerable, and compare different disease models to pinpoint shared mechanisms. The team will use an environmental model of disease to study these neurons in living flies and explore ways to alter their vulnerability. Insights from this work could highlight targets to help protect vulnerable neurons in humans in the future.

Why it matters

Potential benefit: If successful, findings could guide strategies to protect vulnerable neurons in human neurodegenerative diseases.

How similar studies have gone: Previous work in model organisms has shown that certain neurons are more vulnerable, supporting progression toward identifying protective factors.

Where this research is happening

  • Lehigh University
    Bethlehem, United States
    Active

Researchers

  • Principal investigator: Babcock, Daniel T. — Lehigh University
  • Study coordinator: Babcock, Daniel T.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.